Poteligeo ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

poteligeo

kyowa kirin holdings b.v. - mogamulizumab - sezary syndrome; mycosis fungoides - antineoplastiske midler - poteligeo er indisert for behandling av voksne pasienter med mycosis fungoides (mf) eller sézary syndrom (ss) som har mottatt minst én tidligere systemisk terapi.

Vemlidy 25 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

vemlidy 25 mg

orifarm as - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg

Vemlidy 25 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

vemlidy 25 mg

abacus medicine a/s - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg

Onureg ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

onureg

bristol-myers squibb pharma eeig - azacitidin - leukemi, myeloid, akutt - antineoplastiske midler - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).